BrainsWay Ltd. (TLV:BWAY)
2,508.00
0.00 (0.00%)
Oct 12, 2025, 2:27 PM IDT
BrainsWay Revenue
BrainsWay had revenue of $12.63M USD in the quarter ending June 30, 2025, with 26.26% growth. This brings the company's revenue in the last twelve months to $46.08M, up 26.50% year-over-year. In the year 2024, BrainsWay had annual revenue of $41.02M with 29.04% growth.
Revenue (ttm)
$46.08M
Revenue Growth
+26.50%
P/S Ratio
6.14
Revenue / Employee
$384.03K
Employees
120
Market Cap
953.22M ILS
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 41.02M | 9.23M | 29.04% |
Dec 31, 2023 | 31.79M | 4.61M | 16.96% |
Dec 31, 2022 | 27.18M | -2.48M | -8.36% |
Dec 31, 2021 | 29.66M | 7.60M | 34.46% |
Dec 31, 2020 | 22.06M | -1.04M | -4.52% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Teva Pharmaceutical Industries | 56.02B |
Danel (Adir Yeoshua) | 2.84B |
Kamada | 571.15M |
Bait Bakfar | 106.25M |
SofWave Medical | 234.12M |
Ilex Medical | 927.57M |
Novolog (Pharm-Up 1966) | 2.04B |
InterCure | 243.12M |
BrainsWay News
- 17 days ago - Do Options Traders Know Something About Brainsway Stock We Don't? - Nasdaq
- 26 days ago - BWAY Shares Gain on FDA Nod for Accelerated Deep TMS Depression Care - Nasdaq
- 27 days ago - FDA Clearance Boosts BrainsWay (BWAY) Shares - GuruFocus
- 27 days ago - BrainsWay rises as FDA clears accelerated Deep TMS protocol - Seeking Alpha
- 27 days ago - BrainsWay (BWAY) Gains FDA Approval for Enhanced Depression Treatment Protocol - GuruFocus
- 7 weeks ago - BrainsWay Targets Expansion of its Total Addressable Market through a Strategic Investment in Neuromodulation Systems Developer, Neurolief Ltd. - GlobeNewsWire
- 7 weeks ago - BrainsWay Acquires Minority-Stake in Axis Integrated Mental Health - GlobeNewsWire
- 2 months ago - BrainsWay Ltd. (BWAY) Q2 2025 Earnings Call Transcript - Seeking Alpha